Is electrical stimulation an appropriate treatment for constipation in patients with multiple sclerosis after conventional measures have failed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Electrical Stimulation for Constipation in MS

Abdominal functional electrical stimulation (ABFES) is an appropriate treatment option for constipation in MS patients after conventional measures have failed, based on emerging evidence showing significant improvements in quality of life, though sacral nerve stimulation should not be used for constipation management.

Evidence-Based Recommendation

The available guideline evidence addresses defecatory disorders broadly but provides clear direction: sacral nerve stimulation should NOT be used for managing defecatory disorders (constipation) in clinical practice 1. This recommendation is based on limited evidence showing lack of efficacy for constipation specifically.

However, abdominal functional electrical stimulation represents a distinct and promising intervention not addressed in the general gastroenterology guidelines. The MS-specific research evidence demonstrates:

ABFES Efficacy in MS Patients

  • Quality of life improvements are consistently significant across multiple studies 2, 3, 4
  • In the 2019 study, all Patient Assessment of Constipation-related Quality of Life subscales improved significantly: satisfaction (p=0.003), psychosocial discomfort (p=0.008), physical discomfort (p=0.001), and worries/concerns (p=0.003) 2
  • Reduction in laxative use was reported across studies 2, 3
  • Improved sexual functioning was noted as an additional benefit 2

Treatment Protocol

The most effective protocol based on the evidence:

  • 30-60 minutes per session
  • Twice daily for 6 weeks (pilot study) 3 OR 1 hour daily, 5 days/week for 6 weeks 4
  • Applied to abdominal muscles using surface electrodes
  • No adverse effects reported in any study

Important Caveats

Transit time data is mixed: While the 2016 pilot study showed improvements in whole gut transit time (WGTT) and colonic transit time (CTT) 3, the larger 2020 cohort study found no significant changes in these objective measures (WGTT: 81.3 vs 96.1 hours, p=0.160; CTT: 65.1 vs 74.8 hours, p=0.304) 4. However, quality of life still improved significantly despite unchanged transit times, suggesting the mechanism may involve factors beyond simple transit acceleration.

Clinical Algorithm

For MS patients with constipation:

  1. First-line: Conservative measures (diet, fluids, bowel training, laxatives) - per standard guidelines 1

  2. Second-line: Biofeedback therapy if available 1

  3. Third-line consideration: ABFES

    • Particularly appropriate when biofeedback unavailable or failed
    • Requires patient ability to apply device independently or caregiver assistance
    • Non-invasive with no reported adverse effects
    • 6-week trial period reasonable to assess response

  4. Avoid: Sacral nerve stimulation for constipation specifically 1

Distinguishing MS-Specific Context

The general gastroenterology guidelines [1-1] focus on structural defecatory disorders and fecal incontinence, not neurogenic constipation in MS. The MS population has distinct pathophysiology involving demyelination affecting autonomic pathways 5, making ABFES mechanistically appropriate through direct muscle stimulation bypassing compromised neural pathways.

The most recent MS-specific evidence (2019-2020) consistently supports ABFES for quality of life improvement 2, 4, which aligns with prioritizing patient-centered outcomes over purely objective measures like transit time.

References

4
Research

The effect of abdominal functional electrical stimulation on bowel function in multiple sclerosis: a cohort study.

Multiple sclerosis journal - experimental, translational and clinical, 2020

Related Questions

What is the recommended treatment for persistent bloating in an adult patient with multiple sclerosis who also has constipation?
What are the initial recommendations for managing constipation in a patient with multiple sclerosis (MS) on an InterStim (Interstim) bowel regimen?
What is the appropriate management of recurrent ileus in a patient with multiple sclerosis?
Should a patient with multiple sclerosis and digestive symptoms be treated with Creon (pancrelipase), and what initial dose is appropriate?
In a patient with controlled myasthenia gravis, is bromazepam (Lexotan) or lorazepam preferable for anxiety management?
What are the guideline recommendations for monitoring and managing lipid profiles, including the role of apolipoprotein B measurement, and how is cardiovascular risk evaluated and managed in healthy adults presenting for routine check‑up?
What does an interventional radiologist (IR) do?
In a premenopausal patient with HER2‑positive breast cancer, can trastuzumab be given together with goserelin and tamoxifen?
Is amiodarone preferred over bisoprolol for rate control in atrial fibrillation?
Can doxycycline be combined with clindamycin for gastrointestinal infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.